Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
post
Last Updated on: 19 June, 2024|Author: Getaka | Social: X Twitter Profile

Fundamental Analysis of Indoco Remedies Ltd

About the Company - Indoco Remedies Ltd

No data availabale for About the Company
INDUSTRYADDRESSCONTACT
Industry not foundAddress not foundContact not found
Management Data not Available

Basic Stock Data of Indoco Remedies Ltd

Last Updated: June 19, 2024, 2:39 pm

Market Cap 3,006 Cr.
Current Price 326
High / Low417/286
Stock P/E33.8
Book Value 120
Dividend Yield0.68 %
ROCE10.3 %
ROE8.30 %
Face Value 2.00
PEG Ratio1.01

Indoco Remedies Ltd Quarterly Results

MonthDec 2020Mar 2021Jun 2021Sep 2021Dec 2021Mar 2022Jun 2022Sep 2022Dec 2022Mar 2023Jun 2023Sep 2023Dec 2023
Sales332305387387358409408433399428426482459
Expenses272250300300285329337345337363365410397
Operating Profit60558786738171886265617163
OPM %18%18%22%22%21%20%18%20%16%15%14%15%14%
Other Income021100100004-6
Interest65434345798810
Depreciation17192219191820161718202124
Profit before tax38346165516048673839344623
Tax %33%26%35%36%35%32%20%26%26%34%29%24%31%
Net Profit25254042334039502826243516
EPS in Rs2.752.714.304.523.584.394.195.403.052.802.653.811.77

Last Updated: June 7, 2024, 8:54 am

Indoco Remedies Ltd Quarterly Chart

Indoco Remedies Ltd Profit & Loss

Last Updated: June 2, 2024, 12:40 pm

MonthJun 2006Mar 2013Mar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023TTM
Sales2416297318541,0051,0711,0419681,1071,2421,5411,6691,796
Expenses1985376106898349149068929831,0171,2131,3811,536
Operating Profit439312016617115713577123225328288260
OPM %18%15%16%19%17%15%13%8%11%18%21%17%14%
Other Income1212214562321-1
Interest622191112624212622142535
Depreciation6243147616368727173797183
Profit before tax434972110999148-929132237193142
Tax %27%12%20%24%17%15%15%69%16%30%35%26%
Net Profit31435883827741-32493155142101
EPS in Rs3.564.646.298.998.898.364.47-0.312.6210.1016.8015.4411.03
Dividend Payout %23%24%22%18%18%19%22%-95%11%15%13%15%

Indoco Remedies Ltd Profit & Loss Yearly Chart

Indoco Remedies Ltd Growth

Compounded Sales Growth
10 Years:10%
5 Years:13%
3 Years:14%
TTM:9%
Compounded Profit Growth
10 Years:4%
5 Years:103%
3 Years:-2%
TTM:-38%
Stock Price CAGR
10 Years:8%
5 Years:18%
3 Years:-7%
1 Year:-1%
Return on Equity
10 Years:11%
5 Years:12%
3 Years:13%
Last Year:8%

Last Updated: June 15, 2024, 4:39 pm

Indoco Remedies Ltd Balance Sheet

Last Updated: June 2, 2024, 12:40 pm

MonthJun 2006Mar 2013Mar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Sep 2023
Equity Capital12181818181818181818181818
Reserves1873964395005586336576426617518861,0101,050
Borrowings361209297140280282296262267257333496
Other Liabilities76157180230224266281301330279325297374
Total Liabilities3116927298469411,1971,2381,2581,2721,3151,4861,6581,938
Fixed Assets139322325340374440489468590570555678762
CWIP53844635591136185516812211493
Investments60001600000025
Other Assets1613323604434966666136056316778098641,078
Total Assets3116927298469411,1971,2381,2581,2721,3151,4861,6581,938

Indoco Remedies Ltd Reserves and Borrowings Chart

Indoco Remedies Ltd Cash Flow

MonthJun 2006Mar 2013Mar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023
Cash from Operating Activity 3769991091128912313212382174179
Cash from Investing Activity -16-43-41-88-111-171-135-104-56-67-121-208
Cash from Financing Activity -25-24-59-20-2132-39-16-64-30-4423
Net Cash Flow-32-11-050-51123-148-7

Indoco Remedies Ltd Financial Efficiency Indicators

MonthJun 2006Mar 2013Mar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023
Debtor Days1277469666974737469697077
Inventory Days127130148181174189203209230245248228
Days Payable147959514613716615719518311710786
Cash Conversion Cycle1071081221021059711988116197212219
Working Capital Days1167473788081776457107113119
ROCE %20%17%21%17%12%7%1%6%16%23%17%

Indoco Remedies Ltd Financial Efficiency Indicators Chart

Indoco Remedies Ltd Share Holding Pattern

MonthDec 2020Mar 2021Jun 2021Sep 2021Dec 2021Mar 2022Jun 2022Sep 2022Dec 2022Mar 2023Jun 2023Sep 2023
Promoters58.69%58.69%58.69%58.69%58.69%58.69%58.69%58.68%58.68%58.69%58.73%58.75%
FIIs2.88%2.66%2.29%2.43%1.62%1.15%1.17%1.19%1.23%1.55%1.58%1.59%
DIIs17.11%19.26%19.28%17.69%17.78%18.27%18.07%17.97%18.07%18.06%17.93%17.79%
Public21.32%19.39%19.74%21.19%21.91%21.89%22.07%22.16%22.00%21.69%21.75%21.87%
No. of Shareholders24,85221,50824,51834,74637,27937,86338,49838,07235,71334,73135,43136,588

Indoco Remedies Ltd Shareholding Pattern Chart

No. of Indoco Remedies Ltd Shareholders

Indoco Remedies Ltd Mutual Fund Holdings

Fund NameNo of SharesAUM (%)Amount Invested (Cr)Previous Number of SharesPrevious DatePercentage Change
Nippon India Small Cap Fund2,744,5590.2387.221,312,3242024-06-17109.14%
ICICI Prudential Smallcap Fund2,090,6881.1166.441,312,3242024-06-1759.31%
Nippon India Pharma Fund1,834,9241.0558.311,312,3242024-06-1739.82%
Franklin India Smaller Companies Fund1,362,7000.4543.311,312,3242024-06-173.84%
DSP Healthcare Fund1,312,3242.4341.711,312,3242024-06-170%
HDFC Capital Builder Value Fund - Regular Plan673,5890.3821.411,312,3242024-06-17-48.67%
Quant Small Cap Fund609,7930.219.381,312,3242024-06-17-53.53%
Mahindra Manulife Flexi Cap Fund336,9281.0510.711,312,3242024-06-17-74.33%
Quant Healthcare Fund320,2956.310.181,312,3242024-06-17-75.59%
UTI Healthcare Fund271,6981.138.631,312,3242024-06-17-79.3%

Indoco Remedies Ltd ROCE Trend

Indoco Remedies Ltd EPS Trend

Indoco Remedies Ltd Key Financial Ratios

MonthMar 24Mar 23Mar 22Mar 21Mar 20
FaceValue2.002.002.002.002.00
Basic EPS (Rs.)10.5315.4416.8010.102.62
Diluted EPS (Rs.)10.5115.4216.8010.102.62
Cash EPS (Rs.)20.4923.1025.3718.0310.30
Book Value[Excl.RevalReserv]/Share (Rs.)120.44111.5898.1783.4573.75
Book Value[Incl.RevalReserv]/Share (Rs.)120.44111.5898.1783.4573.75
Revenue From Operations / Share (Rs.)197.10181.07167.20134.73120.08
PBDIT / Share (Rs.)27.5731.3035.7724.6813.63
PBIT / Share (Rs.)17.6023.6427.2116.745.95
PBT / Share (Rs.)14.7320.9225.6714.323.10
Net Profit / Share (Rs.)10.5215.4416.8010.102.62
NP After MI And SOA / Share (Rs.)10.6815.4416.8010.102.62
PBDIT Margin (%)13.9817.2821.3918.3111.35
PBIT Margin (%)8.9313.0516.2712.424.95
PBT Margin (%)7.4711.5515.3510.632.58
Net Profit Margin (%)5.338.5210.047.492.17
NP After MI And SOA Margin (%)5.418.5210.047.492.17
Return on Networth / Equity (%)8.8713.8317.1112.093.54
Return on Capital Employeed (%)10.5917.6523.6216.986.74
Return On Assets (%)4.598.5710.417.071.89
Long Term Debt / Equity (X)0.320.130.100.120.14
Total Debt / Equity (X)0.600.300.260.270.29
Asset Turnover Ratio (%)0.951.061.100.950.87
Current Ratio (X)1.561.901.821.531.23
Quick Ratio (X)0.981.141.090.940.77
Inventory Turnover Ratio (X)1.431.291.441.361.34
Dividend Payout Ratio (NP) (%)0.0014.578.920.0011.46
Dividend Payout Ratio (CP) (%)0.009.745.910.002.91
Earning Retention Ratio (%)0.0085.4391.080.0088.54
Cash Earning Retention Ratio (%)0.0090.2694.090.0097.09
Interest Coverage Ratio (X)6.6811.5223.3110.214.79
Interest Coverage Ratio (Post Tax) (X)3.256.6811.955.181.92
Enterprise Value (Cr.)3677.003301.123694.362857.472094.15
EV / Net Operating Revenue (X)2.021.982.402.301.89
EV / EBITDA (X)14.4711.4511.2112.5716.67
MarketCap / Net Operating Revenue (X)1.671.802.252.141.74
Retention Ratios (%)0.0085.4291.070.0088.53
Price / BV (X)2.732.923.843.462.84
Price / Net Operating Revenue (X)1.671.802.252.141.74
EarningsYield0.030.040.040.030.01

Indoco Remedies Ltd Profitability Ratios (%)

Indoco Remedies Ltd Liquidity Ratios

Indoco Remedies Ltd Liquidity Ratios (%)

Indoco Remedies Ltd Interest Coverage Ratios (%)

Indoco Remedies Ltd Valuation Ratios

Fair Value

Fair Value: 338.94

Calculation basis:

  • Fair value = P/E Ratio * (Return on Equity / 100) * Book Value * (1 + Dividend Yield / 100)
  • P/E Ratio (Price-to-Earnings Ratio): Represents the price of the stock relative to its earnings per share. A higher P/E ratio indicates that investors are willing to pay a higher price for the stock.
  • Return on Equity (ROE): Measures a company's profitability relative to its shareholder equity. It showcases the company's ability to generate profits using the investment made by its shareholders, offering valuable insight into its operational efficiency and financial performance
  • Book Value: Represents the net asset value of the company per share. It is calculated as the total assets minus intangible assets and liabilities, divided by the number of outstanding shares.
  • Dividend Yield: The ratio of the annual dividend per share to the current market price per share. It offers valuable insights into the profitability of an investment through dividends.

This formula allows us to gauge the fair value of the stock by analyzing its fundamental indicators.

Undervalued: 3.97% compared to the current price 326

Intrinsic Value: 451.83

Calculation basis:

  • Fair value = P/E Ratio * (Return on Equity / 100) * Book Value * (1 + Dividend Yield / 100) * (1 + EPS CAGR for Last 5 Years)
  • P/E Ratio (Price-to-Earnings Ratio): Represents the price of the stock relative to its earnings per share. A higher P/E ratio indicates that investors are willing to pay a higher price for the stock.
  • Return on Equity (ROE): Measures a company's profitability relative to its shareholder equity. It showcases the company's ability to generate profits using the investment made by its shareholders, offering valuable insight into its operational efficiency and financial performance.
  • Book Value: Represents the net asset value of the company per share. It is calculated as the total assets minus intangible assets and liabilities, divided by the number of outstanding shares.
  • Dividend Yield: The ratio of the annual dividend per share to the current market price per share. It offers valuable insights into the profitability of an investment through dividends.
  • EPS CAGR (Compound Annual Growth Rate): Represents the geometric mean growth rate of earnings per share over the last 5 years. It provides insight into the historical growth trajectory of the company's earnings.

This formula allows us to gauge the fair value of the stock by analyzing its fundamental indicators along with EPS growth.

Undervalued: 38.60% compared to the current price ₹326

Last 5 Year EPS CAGR: 33.31%

*Investments are subject to market risks

Strength and Weakness of Indoco Remedies Ltd Stock

StrengthWeakness
  1. The company has higher reserves (643.85 cr) compared to borrowings (227.54 cr), indicating strong financial stability.
  2. The company has shown consistent growth in sales (263.92 cr) and profit (95.08 cr) over the years.
  1. The stock has a low average ROCE of 13.08%, which may not be favorable.
  2. The stock has a high average Working Capital Days of 86.58, which may not be favorable.
  3. The stock has a high average Cash Conversion Cycle of 132.67, which may not be favorable.

FAQ

What is the latest fair value of Indoco Remedies Ltd?

The latest fair value of Indoco Remedies Ltd is ₹338.94.

What is the Market Cap of Indoco Remedies Ltd?

The Market Cap of Indoco Remedies Ltd is 3,006 Cr..

What is the current Stock Price of Indoco Remedies Ltd as on 19 June 2024?

The current stock price of Indoco Remedies Ltd as on 19 June 2024 is ₹326.

What is the High / Low of Indoco Remedies Ltd stocks in FY 2024?

In FY 2024, the High / Low of Indoco Remedies Ltd stocks is 417/286.

What is the Stock P/E of Indoco Remedies Ltd?

The Stock P/E of Indoco Remedies Ltd is 33.8.

What is the Book Value of Indoco Remedies Ltd?

The Book Value of Indoco Remedies Ltd is 120.

What is the Dividend Yield of Indoco Remedies Ltd?

The Dividend Yield of Indoco Remedies Ltd is 0.68 %.

What is the ROCE of Indoco Remedies Ltd?

The ROCE of Indoco Remedies Ltd is 10.3 %.

What is the ROE of Indoco Remedies Ltd?

The ROE of Indoco Remedies Ltd is 8.30 %.

What is the Face Value of Indoco Remedies Ltd?

The Face Value of Indoco Remedies Ltd is 2.00.

About the Author

Author Avatar
Getaka

Getaka, CFA, a financial analyst with 15 years of experience in the industry. Getaka holds an MBA degree and the Chartered Financial Analyst designation, demonstrating his profound understanding of financial analysis and investment management. Throughout his career, he has conducted numerous financial analyses and due diligence processes for companies in the industry, and has a strong track record of identifying key trends and opportunities. He leverages his expertise to deliver a thorough financial analysis of a company, encompassing its financial performance, key ratios, future prospects, and risks. Getaka is committed to providing accurate, reliable, and trustworthy information to help readers make informed decisions about their finances and investments.

Disclaimer: This article is for informational purposes only and should not be construed as financial advice. The author is not a SEBI registered financial advisor and does not have any vested interest in Indoco Remedies Ltd. Investors are advised to conduct their own due diligence and consult with a financial professional before making any investment decisions. The information provided in this article is based on publicly available data and the author's analysis, but it may not be comprehensive or up-to-date. The author and getaka.co.in are not responsible for any errors or omissions in the content. This article is not intended to promote any particular investment strategy or recommendation, and readers should consult with their own financial advisors before making any investment decisions. Data Source: NSE